Targeting myeloma-osteoclast interaction with Vγ9Vδ2 T cells.
about
Novel immunostimulatory effects of osteoclasts and macrophages on human γδ T cells.Navigating the bone marrow niche: translational insights and cancer-driven dysfunction.Adoptive transfer of ex vivo expanded Vγ9Vδ2 T cells in combination with zoledronic acid inhibits cancer growth and limits osteolysis in a murine model of osteolytic breast cancer.Zoledronic acid causes γδ T cells to target monocytes and down-modulate inflammatory homing.Expansion of Th1-like Vγ9Vδ2T cells by new-generation IMiDs, lenalidomide and pomalidomide, in combination with zoledronic acid.
P2860
Targeting myeloma-osteoclast interaction with Vγ9Vδ2 T cells.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Targeting myeloma-osteoclast interaction with Vγ9Vδ2 T cells.
@en
Targeting myeloma-osteoclast interaction with Vγ9Vδ2 T cells.
@nl
type
label
Targeting myeloma-osteoclast interaction with Vγ9Vδ2 T cells.
@en
Targeting myeloma-osteoclast interaction with Vγ9Vδ2 T cells.
@nl
prefLabel
Targeting myeloma-osteoclast interaction with Vγ9Vδ2 T cells.
@en
Targeting myeloma-osteoclast interaction with Vγ9Vδ2 T cells.
@nl
P2093
P2860
P1476
Targeting myeloma-osteoclast interaction with Vγ9Vδ2 T cells.
@en
P2093
Ayako Nakano
Hiroe Amou
Hirokazu Miki
Hironobu Shibata
Keiichiro Watanabe
Kenichiro Yata
Kumiko Kagawa
Kyoko Takeuchi
Masahiro Abe
P2860
P2888
P356
10.1007/S12185-011-0885-9
P577
2011-06-23T00:00:00Z